109 related articles for article (PubMed ID: 7540240)
21. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
Williams AF
Arch Dis Child; 1993 Sep; 69(3 Spec No):331. PubMed ID: 8215580
[No Abstract] [Full Text] [Related]
22. Iatrogenic neonatal hypertrophic cardiomyopathy.
Gill AW; Warner G; Bull L
Pediatr Cardiol; 1996; 17(5):335-9. PubMed ID: 8660453
[TBL] [Abstract][Full Text] [Related]
23. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
Ng PC
Arch Dis Child; 1993 Mar; 68(3 Spec No):330-6. PubMed ID: 8466274
[No Abstract] [Full Text] [Related]
24. Which course of dexamethasone?
Bloomfield FH; Knight DB; Harding JE
Arch Dis Child Fetal Neonatal Ed; 1999 Jan; 80(1):F80. PubMed ID: 10325825
[No Abstract] [Full Text] [Related]
25. [Tacrolimus and hypertrophic cardiomyopathy].
Romero E; Hevia S; Castellanos D; Simarro C
Med Clin (Barc); 1998 Jun; 110(20):804-5. PubMed ID: 9666425
[No Abstract] [Full Text] [Related]
26. Dexamethasone for neonatal chronic lung disease.
Lancet; 1991 Oct; 338(8773):982-3. PubMed ID: 1681347
[No Abstract] [Full Text] [Related]
27. Tacrolimus-induced hypertrophic cardiomyopathy in a patient with dermatomyositis.
Noda K; Ukichi T; Furuya K; Yoshida K; Kingetsu I; Tanaka T; Kurosaka D
Rheumatology (Oxford); 2017 Nov; 56(11):2037-2038. PubMed ID: 28977571
[No Abstract] [Full Text] [Related]
28. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
Watterberg KL;
Pediatrics; 2010 Oct; 126(4):800-8. PubMed ID: 20819899
[TBL] [Abstract][Full Text] [Related]
29. Progress needed in bronchopulmonary dysplasia.
Mushtaq A
Lancet Respir Med; 2019 Apr; 7(4):300-301. PubMed ID: 30833220
[No Abstract] [Full Text] [Related]
30. Cardiovascular and metabolic side effects associated with hydrocortisone and dexamethasone use in VLBW infants: a single-centre experience.
Röhr SB; Sauer H; Gortner L; Gräber S; Meyer S
Acta Paediatr; 2013 Oct; 102(10):e436. PubMed ID: 23819647
[No Abstract] [Full Text] [Related]
31. Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient.
Turska-Kmieć A; Jankowska I; Pawłowska J; Kaliciński P; Kawalec W; Tomyn M; Markiewicz M; Teisseyre J; Czubkowski P; Rekawek J; Socha J
Pediatr Transplant; 2007 May; 11(3):319-23. PubMed ID: 17430490
[TBL] [Abstract][Full Text] [Related]
32. Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia.
Ng PC; Brownlee KG; Dear PR
Arch Dis Child; 1991 Oct; 66(10 Spec No):1164-6. PubMed ID: 1750771
[TBL] [Abstract][Full Text] [Related]
33. Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants.
Israel BA; Sherman FS; Guthrie RD
Am J Perinatol; 1993 Jul; 10(4):307-10. PubMed ID: 8397569
[TBL] [Abstract][Full Text] [Related]
34. Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia?
Eichenwald EC; Stark AR
Arch Dis Child Fetal Neonatal Ed; 2007 Sep; 92(5):F334-7. PubMed ID: 17712183
[TBL] [Abstract][Full Text] [Related]
35. Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.
Liu T; Gao Y; Gao YL; Cheng YT; Wang S; Li ZZ; Zhang HB; Meng X; Ma CS; Dong JZ
Chin Med J (Engl); 2012 Apr; 125(7):1352-4. PubMed ID: 22613615
[TBL] [Abstract][Full Text] [Related]
36. Hydrocortisone induced hypertrophic cardiomyopathy.
Vimala J; Prabhu A; Pavithran S; Kumar RN
Int J Cardiol; 2011 Aug; 150(3):e94-5. PubMed ID: 20045574
[TBL] [Abstract][Full Text] [Related]
37. Using dexamethasone to treat bronchopulmonary dysplasia.
Van Ekeren RF
Neonatal Netw; 1991 Oct; 10(3):17-21. PubMed ID: 1944082
[No Abstract] [Full Text] [Related]
38. Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia.
Williams AF; Jones M
Arch Dis Child; 1992 Jan; 67(1 Spec No):5-9. PubMed ID: 1536587
[TBL] [Abstract][Full Text] [Related]
39. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
[TBL] [Abstract][Full Text] [Related]
40. Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral.
Baruch Y; Weitzman E; Markiewicz W; Eisenman A; Eid A; Enat R
Transplant Proc; 1996 Aug; 28(4):2250-1. PubMed ID: 8769215
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
